Daniel S Sullivan Stock Trades and Disclosures
Daniel S. Sullivan disclosed stock trades, including selling shares of Constellation Energy (CEG) and Exelon (EXC) in May 2023, and selling shares of Corteva (CTVA), Dow (DOW), IFF, Oracle (ORCL), and DuPont (DD) in early 2021. The transaction amounts ranged from $1,001 to $50,000.
How this was made
The 30-second read
Why it matters
Overall, the filings are low‑impact and unlikely to move the stocks materially.
Market read
Limited relevance; traders may note the sales but no actionable trade signal.
What to watch
Potential tax‑loss harvesting or personal liquidity needs could drive the sales, not company fundamentals.
Background
Form 4 disclosures provide transparency on insider activity; small sales are common and often unrelated to company outlook.
Ticker impact
Form 4 shows Daniel S Sullivan sold between $15,001 and $50,000 of Constellation Energy shares on May 23, 2023.
potential slight downward pressure as market digests the sale
Sale amount is small relative to market cap; no other catalyst disclosed.
Daniel S Sullivan sold between $15,001 and $50,000 of Exelon shares on May 23, 2023 and exchanged a similar amount on Feb 4, 2022.
minor downward pressure
Amounts are small; no material change to ownership.
Daniel S Sullivan sold between $1,001 and $15,000 of Corteva shares on Feb 12, 2021.
no noticeable impact
Sale size is negligible relative to float.
Daniel S Sullivan sold between $1,001 and $15,000 of Dow Inc. shares on Feb 12, 2021.
no material impact
Sale amount is trivial.
Daniel S Sullivan sold between $1,001 and $15,000 of International Flavors & Fragrances shares on Feb 12, 2021.
no noticeable effect
Size is insignificant.
Daniel S Sullivan sold between $15,001 and $50,000 of Oracle shares on Feb 1, 2021.
slight downward pressure possible
Sale is modest relative to Oracle's market cap.
Daniel S Sullivan exchanged between $1,001 and $15,000 of DuPont de Nemours shares on Feb 12, 2021.
no material impact
Transaction size is minimal.
Market effects
No sector-wide implications; isolated insider transactions.
None; trades are US‑based and small.
Minimal; does not affect broader market.
Counterpoint
Given the tiny size, the sales may be routine portfolio rebalancing rather than a negative signal.
Key entities
- InsiderDaniel S Sullivan
Individual filing Form 4 for multiple companies.
